The benefits of newborn screening for cystic fibrosis: The Canadian experience

Journal of Cystic Fibrosis

Volumn 15, Issue 3, 2016, Pages 302-308

  Mak, D Y F ^a   Sykes, J ^b,c   Stephenson, A L ^b,c,f   Lands, L C ^d,e  

^a Canadian Cystic Fibrosis Foundation   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e MONTREAL CHILDREN S HOSPITAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Growth; Hospitalization; Infection; Newborn screening; Nutritional status

Indexed keywords

ARTICLE; BODY MASS; CANADIAN; CHILD; CYSTIC FIBROSIS; DISEASE REGISTRY; FEMALE; HEALTH CARE ACCESS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEWBORN SCREENING; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PERSONAL EXPERIENCE; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; CANADA; COMPLICATION; ECONOMICS; EXOCRINE PANCREATIC INSUFFICIENCY; GOVERNMENT; HEALTH DISPARITY; INFANT; MICROBIOLOGY; NEWBORN; PRESCHOOL CHILD; PROCEDURES; PROGRAM EVALUATION; REGISTER; STATISTICS AND NUMERICAL DATA;

CANADA; CHILD, PRESCHOOL; CYSTIC FIBROSIS; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; GOVERNMENT PROGRAMS; HEALTH STATUS DISPARITIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING; NUTRITIONAL STATUS; PROGRAM EVALUATION; REGISTRIES; RESPIRATORY TRACT INFECTIONS;

EID: 84963964115     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2016.04.001     Document Type: Article

References (31)

1. McKay K., Wilcken B. Newborn screening for cystic fibrosis offers an advantage over symptomatic diagnosis for the long term benefit of patients: the motion for. Paediatr Respir Rev 2008, 9(4):290-294. 10.1016/j.prrv.2008.09.004.
2. Grosse S.D., Boyle C.a, Botkin J.R., et al. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. Morb Mortal Wkly Rep 2004, 53(RR-13):1-36. [http://www.ncbi.nlm.nih.gov/pubmed/15483524].
3. Farrell P.M., Lai H.J., Li Z., et al. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!. J Pediatr 2005, 147(3 Suppl):S30-S36. 10.1016/j.jpeds.2005.08.012.
4. Southern K.W., Munck A., Pollitt R., et al. A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros 2007, 6(1):57-65. 10.1016/j.jcf.2006.05.008.
5. Massie J., Clements B. The Australian Paediatric Respiratory Group. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience-twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group. Pediatr Pulmonol 2005, 39(5):440-446. 10.1002/ppul.20191.
6. Borowitz D., Robinson K.A., Rosenfeld M., et al. Cystic fibrosis foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009, 155(6 Suppl):S73-S93. 10.1016/j.jpeds.2009.09.001.
7. Canadian Organization for Rare Disorders Newborn screening in Canada Status Report https://www.raredisorders.ca/content/uploads/Canada-NBS-status-updated-Sept.-3-2015.pdf.
8. Dankert-Roelse J.E., Mérelle M.E. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe. J Pediatr 2005, 147(3 Suppl):S15-S20. 10.1016/j.jpeds.2005.08.009.
9. CFF: Patient Registry Annual Data Report [Accessed February 9, 2016]. https://www.cff.org/2013_CFF_Patient_Registry_Annual_Data_Report.pdf.
10. VanDevanter D.R., Pasta D.J., Konstan M.W. Improvements in lung function and height among cohorts of 6-year-olds with cystic fibrosis from 1994 to 2012. J Pediatr 2014, 165(6):1091-1097. [e2]. 10.1016/j.jpeds.2014.06.061.
11. Canadian College of Medical Geneticists Newborn screening for cystic fibrosis 2010, 8.
12. Farrell P.M.P., Rosenstein B.J.B., White T.T.B., et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008, 153(2):S4-S14. 10.1016/j.jpeds.2008.05.005.Guidelines.
13. Konstan M.W., Butler S.M., Wohl M.E.B., et al. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 2003, 142(6):624-630. 10.1067/mpd.2003.152.
14. De Onis M., Garza C., Onyango A.W., Rolland-Cachera M.-F. WHO growth standards for infants and young children. Arch Pediatr 2009, 16(1):47-53. 10.1016/j.arcped.2008.10.010.
15. De Onis M., Onyango A.W., Borghi E., Siyam A., Nishida C., Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007, 85(9):660-667. [http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2636412&tool=pmcentrez&rendertype=abstract. Accessed August 16, 2015].
16. Newborn Screening Ontario For health care providers: a discussion guide to help counsel parents about a positive newborn screen for cystic fibrosis 2014, 1.
17. Lilley M., Christian S., Hume S., et al. Newborn screening for cystic fibrosis in Alberta: two years of experience. Paediatr Child Health 2010, 15(9):590-594. [http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3009566&tool=pmcentrez&rendertype=abstract. Accessed March 24, 2016].
18. Cogen J., Emerson J., Sanders D.B., et al. Risk factors for lung function decline in a large cohort of young cystic fibrosis patients. Pediatr Pulmonol 2015, 50(April):763-770. 10.1002/ppul.23217.
19. Simmonds N.J., MacNeill S.J., Cullinan P., Hodson M.E. Cystic fibrosis and survival to 40 years: a case-control study. Eur Respir J 2010, 36(6):1277-1283. 10.1183/09031936.00001710.
20. Goss C.H., Muhlebach M.S. Review: Staphylococcus aureus and MRSA in cystic fibrosis. J Cyst Fibros 2011, 10(5):298-306. 10.1016/j.jcf.2011.06.002.
21. Kahl B.C. Impact of Staphylococcus aureus on the pathogenesis of chronic cystic fibrosis lung disease. Int J Med Microbiol 2010, 300(8):514-519. 10.1016/j.ijmm.2010.08.002.
22. Davies J.C. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Paediatr Respir Rev 2002, 3(2):128-134. [http://www.ncbi.nlm.nih.gov/pubmed/12297059. Accessed June 13, 2015].
23. Cystic Fibrosis Canada The Canadian Cystic Fibrosis Registry: 2013 annual report 2013.
24. Steinkamp G., Wiedemann B. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax 2002, 57(7):596-601. [http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1746376&tool=pmcentrez&rendertype=abstract. Accessed July 20, 2015].
25. Tluczek A., Laxova A., Grieve A., et al. Long-term follow-up of cystic fibrosis newborn screening: psychosocial functioning of adolescents and young adults. J Cyst Fibros 2014, 13(2):227-234. 10.1016/j.jcf.2013.10.001.
26. Sheikh S.I., Long F.R., McCoy K.S., Johnson T., Ryan-Wenger, N.a, Hayes D. Computed tomography correlates with improvement with ivacaftor in cystic fibrosis patients with G551D mutation. J Cyst Fibros 2015, 14(1):84-89. 10.1016/j.jcf.2014.06.011.
27. Dijk F.N., Fitzgerald D.A. The impact of newborn screening and earlier intervention on the clinical course of cystic fibrosis. Paediatr Respir Rev 2012, 13(4):220-225. 10.1016/j.prrv.2012.05.003.
28. Grosse S.D., Rosenfeld M., Devine O.J., Lai H.J., Farrell P.M. Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. J Pediatr 2006, 149(3):362-366. 10.1016/j.jpeds.2006.04.059.
29. Farrell P.M., Kosorok M.R., Rock M.J., et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Pediatrics 2001, 107(1):1-13. 10.1542/peds.107.1.1.
30. Borowitz D., Baker S.S., Duffy L., et al. Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis. J Pediatr 2004, 145(3):322-326. 10.1016/j.jpeds.2004.04.049.
31. Viviani L., Zolin A., Mehta A., Olesen H.V. The European Cystic Fibrosis Society Patient Registry: valuable lessons learned on how to sustain a disease registry. Orphanet J Rare Dis 2014, 9:81. 10.1186/1750-1172-9-81.